Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS Author FAQs
    • COVID-19 submission information
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS Author FAQs
    • COVID-19 submission information
  • Alerts
  • Subscriptions

Challenges in understanding host genetics and severity of community-acquired pneumonia

Jordi Solé-Violán, Elisa Hernández-Brito, José Manuel Valencia-Gallardo, Estefanía Herrera-Ramos, Luis Borderías, M. Luisa Briones, Olga Rajas, Jorge Freixinet, Leonardo Lorente, Antoni Payeras, José Ferreres, Nieves Carbonell, Nereida González-Quevedo, Jesús M. González-Martín, Felipe Rodríguez de Castro, Carlos Rodríguez-Gallego
ERJ Open Research 2021 7: 00745-2020; DOI: 10.1183/23120541.00745-2020
Jordi Solé-Violán
1Intensive Care Unit, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
2CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain
15These authors contributed equally to this work
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisa Hernández-Brito
3Dept of Immunology, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
4Dept of Medical and Surgical Sciences, School of Medicine, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain
15These authors contributed equally to this work
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José Manuel Valencia-Gallardo
5Dept of Respiratory Diseases, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Estefanía Herrera-Ramos
4Dept of Medical and Surgical Sciences, School of Medicine, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Estefanía Herrera-Ramos
Luis Borderías
6Dept of Respiratory Diseases, Hospital San Jorge, Huesca, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Luis Borderías
M. Luisa Briones
7Dept of Respiratory Diseases, Hospital Clínico y Universitario de Valencia, Valencia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olga Rajas
8Dept of Respiratory Diseases, Hospital Universitario de la Princesa, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jorge Freixinet
9Dept of Thoracic Surgery, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonardo Lorente
10Intensive Care Unit, Hospital Universitario de Canarias, La Laguna, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antoni Payeras
11Dept of Internal Medicine, Hospital Son Llatzer, Palma de Mallorca, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José Ferreres
12Intensive Care Unit, Hospital Clínico y Universitario de Valencia, Valencia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nieves Carbonell
12Intensive Care Unit, Hospital Clínico y Universitario de Valencia, Valencia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nereida González-Quevedo
3Dept of Immunology, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jesús M. González-Martín
13Biostatistics Division, Research Unit, Hospital Universitario Dr. Negrín, Las Palmas de Gran Canaria, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jesús M. González-Martín
Felipe Rodríguez de Castro
4Dept of Medical and Surgical Sciences, School of Medicine, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain
5Dept of Respiratory Diseases, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos Rodríguez-Gallego
3Dept of Immunology, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain
14University Fernando Pessoa Canarias, Las Palmas de Gran Canaria, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

This study found no association of the top two associated FER variants with severity of community-acquired pneumonia. Precise characterisation of phenotypes may be required in order to unravel the genetic mechanisms predisposing to poor outcome in sepsis. https://bit.ly/3jc9SmR

To the Editor:

A heritable predisposition to early death due to infection was observed three decades ago [1]. Apart from exciting discoveries in the field of primary immunodeficiencies, genetic variants predisposing to severe infection and outcome at a population level remain largely elusive [2, 3]. Genetic association studies on sepsis were largely based on a candidate gene approach. In 2015, Rautanen et al. [4] reported the first genome-wide association study (GWAS) in sepsis. A meta-analysis of three independent cohorts of critically ill patients with sepsis recruited in numerous centres from Europe, Canada, United States, Australia, New Zealand and South Africa was performed. They reported that the C allele of the single-nucleotide variant (SNV) rs4957796 at the FER gene was associated with a protective additive effect in 28-day survival only in patients with pneumonia, but not in those with other causes of sepsis. Schöneweck et al. [5] did not replicate the findings Rautanen et al. [4] in a mixed cohort of patients of European ancestry with severe sepsis admitted at German intensive care units (ICUs). However, their study was underpowered for mortality. Hinz et al.[6], in a cohort of white patients with acute respiratory distress syndrome (ARDS) due to pneumonia from a single Centre in Germany, found that the rs4957796 TT genotype was associated with a higher 90-day mortality exclusively in the small subgroup of patients with severe ARDS.

We prospectively explored, in a large cohort of ethnically homogeneous patients hospitalised with community-acquired pneumonia (CAP), the potential role of the two top associated SNVs in the FER gene (rs4957796 and rs62375529) [4] in outcome.

Between March 2001 and December 2014, we recruited 1398 patients with CAP at six institutions in Spain. Foreigners and individuals with ancestors other than Spanish were previously excluded. DNA samples from 960 patients were available and successfully analysed for the rs4957796 and rs62375529 SNVs. CAP, severe sepsis, septic shock, and ARDS were diagnosed as previously reported [7–9]. Empirical antibiotic therapy was appropriate according to American Thoracic Society/Infectious Diseases Society of America guidelines in 87% of patients. Patients were observed for 90 days after hospital discharge or death. The control group consisted of 996 unrelated healthy volunteers and patients without a previous history of relevant infections of the same ethnicity as CAP patients. Genomic DNA was obtained as previously described [7–9]. Analyses of single-nucleotide polymorphisms (SNPs) were performed by pre-designed Taqman SNP genotyping assays (C__28002866_10 [rs4957796] and C__90533619_10 [rs62375529]) with commercially available reagents by means of ViiA™7 Real-time PCR System (Applied Biosystems, Foster City, CA, USA). Informed consent was obtained from the patients or their relatives. The protocol was approved by the local ethics committee of the six hospitals. All steps were performed in complete accordance with the Helsinki declaration.

Causative microorganisms were identified in 460 patients (47.9%), and 59% of the cases were due to Streptococcus pneumoniae. A total of 338 patients were admitted to the ICU; 64 developed ARDS, 108 developed severe sepsis and 214 developed septic shock. Bacteraemia was observed in 119 patients (12.4%), caused by S. pneumoniae in 86 cases.

Genotype distribution of both SNPs did not differ significantly under conditions of Hardy–Weinberg equilibrium in the control group. The allelic frequencies under analysis were not significantly different between patients with CAP and the control group (table 1); no differences were observed when only patients with pneumococcal CAP were considered (data not shown). When an additive logistic regression analysis was performed, the FER rs4957796 and rs62375529 SNVs did not confer significant risk for need of ICU admission, development of sepsis, severe sepsis/septic shock, ARDS, 28-day mortality, or 90-day mortality (table 1). No associations were found when the analysis of mortality was restricted to patients with sepsis or severe sepsis/septic shock (table 1). At a significance level of 5% and 80% power, the relative risk to detect a significant allelic association of rs4957796 was 1.76, 1.44 and 1.82 for ARDS, severe sepsis/septic shock and 28-day mortality, respectively. Conversely, the rs62375529 CC genotype was over-represented in patients who developed severe sepsis/septic shock, and a weak association with 28-day mortality was also observed (table 1). After adjustment for age, sex, comorbidities and admitting hospital, the rs62375529 FER variant remained significantly associated with severe sepsis risk (OR=5.17; 95% CI 1.96–13.68, p=0.001). The association of the rs62375529 FER SNV with 28-day mortality did not remain significant after corrections for multiple testing. However, the association of rs62375529 with development of severe sepsis/septic shock, was still significant after correction for multiple comparisons (eight phenotype comparison for each allele). These results were surprising, as Rautanen et al. [4] found that the C allele of rs62375529 was associated with an additive effect to a higher 28-day survival in their cohort of patients with pneumonia and severe sepsis.

View this table:
  • View inline
  • View popup
TABLE 1

Genotype data of patients with community-acquired pneumonia (CAP)

Formal validation is essential to confirm findings observed in a GWAS and usually requires large sample sizes, a homogeneous ethnic background, a precise phenotype definition and a clear identification of other involved risk factors [10, 11]. Phenotype definitions may vary considerably across studies and may be a source of contradictory results [11]. The severity, as well as the immune and inflammatory response, in patients with pneumonia can be considered as a continuum of disease, ranging from CAP to the development of sepsis, septic shock, ARDS and multiple organ dysfunction syndrome. Therefore, there may be some overlap between CAP and CAP-induced sepsis, which could overshadow the association between genotype and phenotype. Our cohort was composed of patients hospitalised with CAP with different degrees of disease severity. In contrast, the association reported by Rautanen et al. [4], focused exclusively in ICU patients with pneumonia-associated sepsis. Although the majority of pneumonias were classified as CAP, the type of pneumonia was not specified in 24.7% of patients. We documented a causative organism in 47.9% of our patients (mainly S. pneumoniae). In the study of Rautanen et al. [4] between 49% and 63% of pulmonary infections were caused by Gram-positive bacteria, but the proportion of S. pneumoniae was not specified. These differences may be relevant because the inflammatory and immune response varies depending on the source of infection and the causative pathogen [11].

Our study may be underpowered to detect clinically relevant differences, particularly for the mortality end-point. In any case, our sample is sufficient to detect a relative risk for 28-day mortality of 1.82, 3.55 and 2.00 in the entire population, and in the subgroups of patients with sepsis and severe sepsis/septic shock respectively, at a significance threshold of 0.05 with 80% power. However, our study was still underpowered to detect an effect on mortality in patients admitted to ICU.

Intriguingly, we found a directionally inconsistent association for the rs62375529 variant between our results and those of Rautanen et al. [4]. Data from Schöneweck et al. [5] were extracted from a GWAS [12] in which the 14 top associations at 12 loci from Rautanen et al. [4] were compared. They found that only two of these variants were weakly associated with 28-day mortality. However, the alleles’ effect in both GWASs were also directionally inconsistent [12]. Associations of opposite alleles at the same biallelic locus with the same disease, usually referred to as “flip-flop” associations, are confusing findings, particularly when they are observed in the same ethnic group [13, 14]. Flip-flop associations may result from heterogeneous effects of the same variant due to differences in genetic background, environment or comorbidities. In addition, differences in linkage disequilibrium (LD) architectures or LD patterns between populations could also lead to flip-flop associations. Variation in LD architecture across different populations is common in populations of different ethnic origin, but it has been also observed among populations within the same ethnic group [13, 14]. Larger heterozygosity in Southern compared with Northern European populations has been reported [15]. Noteworthy, the minor allele frequencies at the rs4957796 and rs62375529 SNVs are significantly lower in Southern European, particularly in Spanish, than in Northern European populations from the 1000 Genomes Project (http://phase3browser.1000genomes.org). Likewise, LD between both SNVs is also lower in Southern European than in Northern European populations (for instance, D′ is 0.78 in our control population versus 0.97 and 0.94 in the Finnish (FIN) and European (CEU) populations from 1000 Genomes Project, respectively). These differences between populations, and a different extent of LD of the rs4957796 SNV with a putative, or different, causal variants, might be the cause of the observed directionally inconsistent associations.

In an ethnically homogeneous population of patients with CAP, we could not confirm the protective effect of the rs4957796 C allele within the FER gene, but we found a directionally inconsistent association for the rs62375529 variant. Genetic variants may have a different impact depending on different populations, causative microorganism, source of infection and severity of disease.

Due to differences such as phenotype definition and sampling strategy, our study cannot be considered a formal replication of the results of the Rautanen et al. [4] study. In any case, we have not been able to reproduce these results in patients hospitalised with CAP, Our results emphasise the importance of replicating the results of GWASs, and illustrates some of the bias that can occur as well as the challenges of translating the finding of FER variants as predictors of mortality into clinical practice. Further research is needed to better delineate the extent of the role of FER variants in sepsis severity. A more precisely characterisation of sepsis phenotypes may be required in order to unravel the genetic mechanism predisposing to sepsis severity.

Acknowledgments

We are grateful to the patients and healthy individuals for their trust.

Footnotes

  • Conflict of interest: J. Solé-Violán has nothing to disclose.

  • Conflict of interest: E. Hernández-Brito has nothing to disclose.

  • Conflict of interest: J.M. Valencia-Gallardo has nothing to disclose.

  • Conflict of interest: E. Herrera-Ramos has nothing to disclose.

  • Conflict of interest: L. Borderías reports personal fees, nonfinancial support and other from GSK, personal fees from Allergy Therapeutics, nonfinancial support from Novartis, Boehringer and Esteve Teijin, personal fees from AstraZeneca, and nonfinancial support from Menarini, outside the submitted work.

  • Conflict of interest: M.L. Briones has nothing to disclose.

  • Conflict of interest: O. Rajas has nothing to disclose.

  • Conflict of interest: J. Freixinet has nothing to disclose.

  • Conflict of interest: L. Lorente has nothing to disclose.

  • Conflict of interest: A. Payeras has nothing to disclose.

  • Conflict of interest: J. Ferreres has nothing to disclose.

  • Conflict of interest: N. Carbonell has nothing to disclose.

  • Conflict of interest: N. González-Quevedo has nothing to disclose.

  • Conflict of interest: J.M. González-Martin has nothing to disclose.

  • Conflict of interest: F. Rodríguez de Castro has nothing to disclose.

  • Conflict of interest: C. Rodríguez-Gallego has nothing to disclose.

  • Support statement: This work was partially supported by grants from the Instituto de Salud Carlos III, Ministry of Health (FIS PI13/01456 and PI16/00759) to C. Rodríguez-Gallego, with the funding of European Regional Development Fund–European Social Fund (FEDER-FSE), from Grupo DISA (OA18/017) to C. Rodríguez-Gallego and from SEPAR (Spanish Society of Pulmonology and Thoracic Surgery-Fundación Española del Pulmón) to F. Rodríguez de Castro; E. Hernández-Brito and E. Herrera-Ramos were supported by grants from Universidad de Las Palmas de Gran Canaria. Funding information for this article has been deposited with the Crossref Funder Registry.

  • Received October 11, 2020.
  • Accepted October 13, 2020.
  • Copyright ©ERS 2021
http://creativecommons.org/licenses/by-nc/4.0/

This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

References

  1. ↵
    1. Sørensen TI,
    2. Nielsen GG,
    3. Andersen PK, et al.
    Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 1988; 318: 727–732. doi:10.1056/NEJM198803243181202
    OpenUrlCrossRefPubMed
  2. ↵
    1. Casanova JL,
    2. Abel L
    . Human genetics of infectious diseases: unique insights into immunological redundancy. Semin Immunol 2018; 36: 1–12. doi:10.1016/j.smim.2017.12.008
    OpenUrlCrossRef
  3. ↵
    1. Casanova JL
    . Human genetic basis of interindividual variability in the course of infection. Proc Natl Acad Sci USA 2015; 112: 7118–7127. doi:10.1073/pnas.1521644112
    OpenUrl
  4. ↵
    1. Rautanen A,
    2. Mills TC,
    3. Gordon AC, et al.
    Genome-wide association study of survival from sepsis due to pneumonia: an observational cohort study. Lancet Respir Med 2015; 3: 53–60. doi:10.1016/S2213-2600(14)70290-5
    OpenUrl
  5. ↵
    1. Schöneweck F,
    2. Kuhnt E,
    3. Scholz M, et al.
    Common genomic variation in the FER gene: useful to stratify patients with sepsis due to pneumonia? Intensive Care Med 2015; 41: 1379–1381. doi:10.1007/s00134-015-3829-7
    OpenUrl
  6. ↵
    1. Hinz J,
    2. Büttner B,
    3. Kriesel F, et al.
    The FER rs4957796 TT genotype is associated with unfavorable 90-day survival in Caucasian patients with severe ARDS due to pneumonia. Sci Rep 2017; 7: 9887. doi:10.1038/s41598-017-08540-7
    OpenUrl
  7. ↵
    1. Solé-Violán J,
    2. García-Laorden MI,
    3. Marcos-Ramos JA, et al.
    The Fcγ receptor IIA-H/H131 genotype is associated with bacteremia in pneumococcal community-acquired pneumonia. Crit Care Med 2011; 39: 1388–1393. doi:10.1097/CCM.0b013e31820eda74
    OpenUrlCrossRefPubMed
    1. Martín-Loeches I,
    2. Solé-Violán J,
    3. Rodríguez de Castro F, et al.
    Variants at the promoter of the interleukin-6 gene are associated with severity and outcome of pneumococcal community-acquired pneumonia. Intensive Care Med 2012; 38: 256–262. doi:10.1007/s00134-011-2406-y
    OpenUrlCrossRefPubMed
  8. ↵
    1. García-Laorden MI,
    2. Rodríguez de Castro F,
    3. Solé-Violán J, et al.
    The role of mannose-binding lectin in pneumococcal infection. Eur Respir J 2013; 41: 131–139. doi:10.1183/09031936.00174111
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. König IR
    . Validation in genetic association studies. Brief Bioinform 2011; 12: 253–258. doi:10.1093/bib/bbq074
    OpenUrlCrossRefPubMed
  10. ↵
    1. Goh C,
    2. Knight JC
    . Enhanced understanding of the host-pathogen interaction in sepsis: new opportunities for omic approaches. Lancet Respir Med 2017; 5: 212–223. doi:10.1016/S2213-2600(17)30045-0
    OpenUrl
  11. ↵
    1. Scherag A,
    2. Schöneweck F,
    3. Kesselmeier M, et al.
    Genetic factors of the disease course after sepsis: a genome-wide study for 28-day mortality. EBioMedicine 2016; 12: 239–246. doi:10.1016/j.ebiom.2016.08.043
    OpenUrl
  12. ↵
    1. Lin PI,
    2. Vance JM,
    3. Pericak-Vance MA, et al.
    No gene is an island: the flip-flop phenomenon. Am J Hum Genet 2007; 80: 531–538. doi:10.1086/512133
    OpenUrlCrossRefPubMed
  13. ↵
    1. Clarke GM,
    2. Cardon LR
    . Aspects of observing and claiming allele flips in association studies. Genet Epidemiol 2010; 34: 266–274. doi:10.1002/gepi.20458
    OpenUrlPubMed
  14. ↵
    1. Taudien S,
    2. Lausser L,
    3. Giamarellos-Bourboulis EJ, et al.
    Genetic factors of the disease course after sepsis: rare deleterious variants are predictive. EBioMedicine 2016; 12: 227–238. doi:10.1016/j.ebiom.2016.08.037
    OpenUrl
PreviousNext
Back to top
Vol 7 Issue 1 Table of Contents
ERJ Open Research: 7 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Challenges in understanding host genetics and severity of community-acquired pneumonia
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Challenges in understanding host genetics and severity of community-acquired pneumonia
Jordi Solé-Violán, Elisa Hernández-Brito, José Manuel Valencia-Gallardo, Estefanía Herrera-Ramos, Luis Borderías, M. Luisa Briones, Olga Rajas, Jorge Freixinet, Leonardo Lorente, Antoni Payeras, José Ferreres, Nieves Carbonell, Nereida González-Quevedo, Jesús M. González-Martín, Felipe Rodríguez de Castro, Carlos Rodríguez-Gallego
ERJ Open Research Jan 2021, 7 (1) 00745-2020; DOI: 10.1183/23120541.00745-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Challenges in understanding host genetics and severity of community-acquired pneumonia
Jordi Solé-Violán, Elisa Hernández-Brito, José Manuel Valencia-Gallardo, Estefanía Herrera-Ramos, Luis Borderías, M. Luisa Briones, Olga Rajas, Jorge Freixinet, Leonardo Lorente, Antoni Payeras, José Ferreres, Nieves Carbonell, Nereida González-Quevedo, Jesús M. González-Martín, Felipe Rodríguez de Castro, Carlos Rodríguez-Gallego
ERJ Open Research Jan 2021, 7 (1) 00745-2020; DOI: 10.1183/23120541.00745-2020
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Respiratory infections and tuberculosis
  • Genetics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Duration of RA and the risk of developing ILD
  • Prevalence of stress urinary incontinence in chronic cough
  • What is important for people with NTM?
Show more Original research letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2021 by the European Respiratory Society